280 related articles for article (PubMed ID: 26799472)
1. TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.
Rapoport B; McLachlan SM
Endocr Rev; 2016 Apr; 37(2):114-34. PubMed ID: 26799472
[TBL] [Abstract][Full Text] [Related]
2. Withdrawn: TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.
Rapoport B; McLachlan SM
Endocr Rev; 2016 Feb; 2016(1):23-42. PubMed ID: 27454362
[TBL] [Abstract][Full Text] [Related]
3. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
4. Subunit interactions influence TSHR multimerization.
Latif R; Michalek K; Davies TF
Mol Endocrinol; 2010 Oct; 24(10):2009-18. PubMed ID: 20719860
[TBL] [Abstract][Full Text] [Related]
5. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
6. Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Apr; 144(4):1324-30. PubMed ID: 12639915
[TBL] [Abstract][Full Text] [Related]
7. Role of cleavage and shedding in human thyrotropin receptor function and trafficking.
Quellari M; Desroches A; Beau I; Beaudeux E; Misrahi M
Eur J Biochem; 2003 Sep; 270(17):3486-97. PubMed ID: 12919313
[TBL] [Abstract][Full Text] [Related]
8. Functional assessment of the thyrotropin receptor-beta subunit.
Ciullo I; Latif R; Graves P; Davies TF
Endocrinology; 2003 Jul; 144(7):3176-81. PubMed ID: 12810574
[TBL] [Abstract][Full Text] [Related]
9. Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor.
Latif R; Ando T; Davies TF
Endocrinology; 2004 Dec; 145(12):5580-8. PubMed ID: 15319351
[TBL] [Abstract][Full Text] [Related]
10. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.
Chen CR; Pichurin P; Nagayama Y; Latrofa F; Rapoport B; McLachlan SM
J Clin Invest; 2003 Jun; 111(12):1897-904. PubMed ID: 12813025
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin.
Kaczur V; Puskas LG; Nagy ZU; Miled N; Rebai A; Juhasz F; Kupihar Z; Zvara A; Hackler L; Farid NR
J Mol Recognit; 2007; 20(5):392-404. PubMed ID: 18074395
[TBL] [Abstract][Full Text] [Related]
13. Subunit structure of thyrotropin receptors expressed on the cell surface.
Tanaka K; Chazenbalk GD; McLachlan SM; Rapoport B
J Biol Chem; 1999 Nov; 274(48):33979-84. PubMed ID: 10567361
[TBL] [Abstract][Full Text] [Related]
14. Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization.
Pichurin PN; Chen CR; Chazenbalk GD; Aliesky H; Pham N; Rapoport B; McLachlan SM
J Immunol; 2006 Jan; 176(1):668-76. PubMed ID: 16365463
[TBL] [Abstract][Full Text] [Related]
15. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
[TBL] [Abstract][Full Text] [Related]
16. An N-linked glycosylation motif from the noncleaving luteinizing hormone receptor substituted for the homologous region (Gly367 to Glu369) of the thyrotropin receptor prevents cleavage at its second, downstream site.
Kakinuma A; Chazenbalk GD; Tanaka K; Nagayama Y; McLachlan SM; Rapoport B
J Biol Chem; 1997 Nov; 272(45):28296-300. PubMed ID: 9353284
[TBL] [Abstract][Full Text] [Related]
17. Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.
Morshed SA; Davies TF
Horm Metab Res; 2015 Sep; 47(10):727-34. PubMed ID: 26361259
[TBL] [Abstract][Full Text] [Related]
18. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites.
Chazenbalk GD; Tanaka K; Nagayama Y; Kakinuma A; Jaume JC; McLachlan SM; Rapoport B
Endocrinology; 1997 Jul; 138(7):2893-9. PubMed ID: 9202233
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
